Adam Lambert, PhD, is the VP, product and process development, for Pharmatech Associates, a USP company.
Common FDA 483 Observations for Combination Products
Any improper validation of methods is likely to result in regulatory agency deficiencies that range in degree of severity.
A Method Validation Framework for Combination Products
The importance of getting buy-in from regulatory authorities early in the development process is critical in order to establish meaningful specifications.